http://www.fpnotebook.com/
Monoamine Oxidase InhibitorAka: MAO inhibitor, Phenelzine, Nardil, Tranylcypromine, Parnate
- Indications: Comorbid Depression
- Anxiety Disorder
- Atypical Depression
- Refractory Depression
- Bulimia
- Social Phobia
- Mechanism
- Inhibits monoamine oxidase
- Increases synaptic concentration of monoamines
- Precautions
- Tyramine-free diet must be followed
- Continue for two weeks after stopping medication
- See Tyramine Containing Foods
- Stop 2 weeks before starting another Antidepressant
- Taper Nardil slowly when stopping
- See Antidepressant Withdrawal
- Reduce dose by 15 mg/day every 2 weeks (or 10%/week)
- Tyramine-free diet must be followed
- Preparations: Hydrazine
- Isocarboxazid (Marplan): No longer manufactured in U.S.
- Dosing: 10 mg PO bid
- Maximum: 60 mg per day
- Phenelzine (Nardil)
- Dosing: 15 mg PO tid
- Maximum: 90 mg per day
- Isocarboxazid (Marplan): No longer manufactured in U.S.
- Preparations Non-hydrazine
- Tranylcypromine (Parnate)
- Dosing: 10-40 mg/day in divided doses
- Maximum: 60 mg per day
- Parkinsonian agents
- Selegiline (Eldepryl)
- Tranylcypromine (Parnate)
- Complications
- Hypertensive Crisis (life-threatening)
- Occurs if tyramine or Sympathomimetic exposure
- Serotonin Syndrome
- Occurs with concurrent use of Serotoninergic drug
- Hypertensive Crisis (life-threatening)
- Drug Interactions (Do not use with these medications)
- Adverse Effects
- Anti-Histaminergic effects
- Dizziness
- Sedation
- Orthostatic Hypotension
- Weight gain
- Dopaminergic effects
- Insomnia
- Myoclonal jerks
- Serotoninergic Effects
- Sexual dysfunction
- Headache
- Anticholinergic Toxicity
- Dry Mouth
- Constipation
- Blurred Vision
- Urinary hesitancy
- Nausea
- Memory Dysfunction
- Other Effects
- Peripheral edema
- Weakness
- Anti-Histaminergic effects
Phenelzine (C0031392) | |
|---|---|
| Definition (MSH) | One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC. |
| Definition (CSP) | monoamine oxidase inhibitor used to treat depression and phobic disorders. |
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D010624 |
| English | 2 Phenethylhydrazine, 2-Phenethylhydrazine, beta Phenylethylhydrazine, beta-Phenylethylhydrazine, Fenelzin, MAOI - Phenelzine, Phenelzine, PHENELZINE PREPARATION, Phenethylhydrazine |
| Spanish | fenelcina, fenelzina |
| Parent Concepts | Monoamine Oxidase Inhibitors (C0026457), Antidepressive Agents (C0003289), Hydrazines (C0020233), [CN602] MONOAMINE OXIDASE INHIBITOR ANTIDEPRESSANTS (C0973505), Monoamine oxidase A inhibitor (C1629501), Monoamine Oxidase (Type A) Inhibitors (C1579359) |
| Sources | AOD, CSP, LNC, MSH, NCI, NDFRT, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
Tranylcypromine (C0040778) | |
|---|---|
| Definition (MSH) | A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. (From AMA Drug Evaluations Annual, 1994, p311) |
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D014191 |
| English | MAOI - Tranylcypromine, trans 2 Phenylcyclopropylamine, trans-2-Phenylcyclopropylamine, Tranylcypromine, TRANYLCYPROMINE PREPARATION |
| Spanish | tranilcipromina |
| Parent Concepts | Propylamines (C0033504), Monoamine Oxidase Inhibitors (C0026457), [CN602] MONOAMINE OXIDASE INHIBITOR ANTIDEPRESSANTS (C0973505), Monoamine oxidase A inhibitor (C1629501), Monoamine Oxidase (Type A) Inhibitors (C1579359) |
| Sources | LNC, MSH, NCI, NDFRT, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
Nardil (C0701388) | |
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D010624 |
| English | Nardil, Parke Davis Brand of Phenelzine Sulfate, Pfizer Brand of Phenelzine Sulfate, United Drug Brand of Phenelzine Sulfate |
| Sources | AOD, MSH, NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
Parnate (C0701426) | |
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D014191 |
| English | Allphar Brand of Tranylcypromine Sulfate, GlaxoSmithKline Brand of Tranylcypromine Sulfate, Goldshield Brand of Tranylcypromine Sulfate, Link Brand of Tranylcypromine Sulfate, Parnate, SmithKline Brand of Tranylcypromine Sulfate |
| Sources | MSH, NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |